● ArisGlobal announces acquisition of Boehringer Ingelheim’s Benefit-Risk Analytic System ...
Life sciences technology leader welcomes five executives to elevate the ...
LifeSphere Clinical continues to make a substantial industry impact providing ...
ArisGlobal’s LifeSphere sees significant uptake of clinical software adoption in ...
In person attendance, speaking session, and LifeSphere Regulatory demos mark ...
MIAMI, FL - March 18, 2022 - ArisGlobal®, the leading ...
ArisGlobal’s signature R&D Safety suite continues to record substantial global ...
Leading automated drug development technology platform LifeSphere recognized for outstanding ...
ArisGlobal’s industry-leading regulatory software chosen by top pharmaceutical company for ...
LifeSphere product leaders share insight into how an effective IDMP ...
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 500 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2024 ArisGlobal – All Rights Reserved